Dec 30, 2022 by Jason HawthorneDown 70%, This Stock Could Get Cut in Half AgainDespite the risk, I still own shares.
Dec 21, 2022 by Jason HawthorneCathy Wood Bailed Out of This Stock. And I'm Jumping InAfter a 90% drop, it's worth the risk.
Dec 14, 2022 by Jason HawthorneIs Illumina Cheap or Expensive?It depends on which numbers you focus on.
Dec 5, 2022 by Jason HawthorneCould This Beaten-Down Stock Be the Next 100-Bagger?Investors could hit the jackpot if the pieces fall into place.
Oct 26, 2022 by Jason HawthorneDown 90%, Is the Worst Over for Teladoc Shareholders?If you look closely at the dark clouds, you can see a silver lining.
Oct 3, 2022 by Jason HawthorneDown 40%, This Well-Known Company Is Paying Its Highest Dividend Yield EverAnd the distribution seems surprisingly safe.
Sep 26, 2022 by Jason HawthorneDown 80%, Is Shopify Stock Worth the Risk?The numbers might surprise you.
Sep 19, 2022 by Jason Hawthorne1 Risk That Might Surprise Alphabet ShareholdersAnd estimating how much it could affect the stock price.
Aug 30, 2022 by Jason Hawthorne3 Reasons This Big Tech Stock Is No. 1 on My Buy ListIt's a great choice for those who want to stay invested and still sleep well at night.
May 10, 2022 by Jason HawthorneDid This Company Make a Tight Labor Market Worse?It's having a tough time digesting all of the hires it made during the pandemic.
May 4, 2022 by Jason HawthorneLooking Back at Hot Tech IPOs From a Decade AgoWhat investors can learn from recent history.
Apr 30, 2022 by Jason Hawthorne1 Surprising Stock That Has Significant Exposure to Russia and UkraineDespite the risk, its stock hasn't dropped at all.
Apr 29, 2022 by Jason Hawthorne3 Things About BioNTech That Smart Investors KnowIt's unlikely to be a one-hit wonder. And that should be great for patient investors.
Apr 29, 2022 by Jason Hawthorne3 Trustworthy CEOs With Different Perspectives on InflationAre they telling the same story?
Apr 29, 2022 by Jason Hawthorne5 Charts That Tell the Story of TeladocShareholders have seen a play in three acts: promotion, arrogance, and denial.
Apr 28, 2022 by Jason Hawthorne2 Reasons to Buy Illumina, and 1 Reason to SellShares are near a 52-week low, but is that cheap enough?
Apr 28, 2022 by Jason Hawthorne2 Reasons to Buy Thermo Fisher Scientific, and 1 Reason to SellThe life sciences giant could end up being a victim of its own success.
Apr 27, 2022 by Jason HawthorneWill Amazon's Crown Jewel Continue to Shine?Investors might find out its dominance is waning.
Apr 27, 2022 by Jason Hawthorne1 Surprising Key to Apple's Stock ReturnsThe upcoming earnings report should indicate if it will continue.
Apr 27, 2022 by Jason Hawthorne5 Charts That Show Which Home Improvement Retailer Can Help Build Your PortfolioThey might seem interchangeable to consumers, but Wall Street sees a big difference.
